PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,410 | +153.8% | 1,444,000 | +84.5% | 2.53% | +150.0% |
| Q4 2022 | $15,131 | -99.9% | 782,788 | 0.0% | 1.01% | -11.5% |
| Q3 2022 | $16,352,000 | +323.2% | 782,788 | +62.3% | 1.14% | +291.4% |
| Q2 2022 | $3,864,000 | +14.3% | 482,413 | 0.0% | 0.29% | +12.3% |
| Q1 2022 | $3,382,000 | -48.1% | 482,413 | 0.0% | 0.26% | -32.8% |
| Q4 2021 | $6,513,000 | -20.0% | 482,413 | 0.0% | 0.39% | +16.9% |
| Q3 2021 | $8,143,000 | -42.0% | 482,413 | 0.0% | 0.33% | -30.6% |
| Q2 2021 | $14,048,000 | -41.6% | 482,413 | -21.1% | 0.48% | -11.0% |
| Q1 2021 | $24,047,000 | +73.1% | 611,409 | 0.0% | 0.54% | +61.9% |
| Q4 2020 | $13,891,000 | +2.4% | 611,409 | 0.0% | 0.33% | -36.6% |
| Q3 2020 | $13,571,000 | -27.9% | 611,409 | 0.0% | 0.52% | -27.3% |
| Q2 2020 | $18,812,000 | – | 611,409 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |